Adherence to drug therapy in kidney disease

Magacho, E.J.C.; Ribeiro, Luíz Cláudio; Chaoubah, Alfredo; Bastos, Marcus Gomes

doi:10.1590/s0100-879x2011007500013

Cited by 51 publications

(59 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus there is a significant (p>0.05) improvement in medication adherence at the end of the study. In a study E. J. C. Magacho, et al [4] compared baseline adherence with final review among the dialysis patients and concluded that non-adherence to medication was identified in 17.4% of patients with kidney disease and increased during the next 12 mo of the disease course to 26.8%.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Impact of Pharmaceutical Care on Improving Knowledge and Medication Adherence in CKD Patients

Baby

Antony

Wilson

et al. 2016

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Objectives: Evaluation of the impact of pharmaceutical care on improving knowledge and medication adherence in Chronic Kidney Disease (CKD) patients.Methods: Patient data were recorded on a data collection form after informed consent. Their knowledge and medication adherence were evaluated by questionnaire and it was quantified. Patients were counselled using patient information leaflets. Re-assessment was made during follow-up.Results: Medication adherence among patients was classified as low, medium and high adherence. Knowledge was classified under three categories excellent, average and poor. There was a considerable improvement in knowledge and medication adherence irrespective of age and gender. The study was statistically significant with P<0.05. Conclusion:The efforts to increase awareness on CKD patients such as providing patient counselling and continuous education could enhance adherence to therapies and thus could improve clinical outcomes and quality of life.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of Impact of Pharmaceutical Care on Improving Knowledge and Medication Adherence in CKD Patients

Baby

Antony

Wilson

et al. 2016

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

show abstract

“…In one of the study in patients with CKD 17.4 % were found non-adherent to medication at baseline and 26.8% at 1 year. [10] There is a need of uniform definition of being non-adherent, as many patients report adherence according to personal definitions rather than conventional scientific concepts of nonadherence. Number of medicines per prescription affects inversely to adherence score.…”

Section: Discussionmentioning

confidence: 99%

“…[1] It is a prolonged illness usually coexisting with diseases such as hypertension and diabetes. Consequently, these patients have to take a large pill burden on an average around [8][9][10] tablets/day. [2] This imposes high personal and monetary burden on patients and their families.…”

Section: Introductionmentioning

confidence: 99%

“…Previous studies have reported 26-28% CKD patients to be non-adherent. [9] Reasons for non-adherence have been shown to vary depending on disease [10,11] and characteristics of medicines prescribed. [12] Hence, it is necessary to understand non-adherence to medication in a particular disease and study factors affecting it.…”

Section: Introductionmentioning

confidence: 99%

“…Various studies have reported factors such as polypharmacy, psychological factors to be responsible. [10,14] Other factors such as financial constraints, patients' beliefs, and adverse drug reactions may be responsible for non-adherence. Hence, this study was planned to evaluate the extent of medication non-adherence within the CKD population and study factors responsible for the same.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations